Colgate-Palmolive director receives stock and options

Colgate-Palmolive director Harris C. Martin received new equity awards.

Rhea-AI Filing Summary

Colgate-Palmolive director Harris C. Martin received new equity awards. On May 11, 2026, he was granted 1,556 shares of Common Stock as an annual director stock grant under the company’s incentive compensation plan.

He was also granted stock options for 2,424 shares of Common Stock with an exercise price of $86.74 per share, expiring on May 11, 2034. These options become exercisable in equal annual installments over three years beginning on the first anniversary of the grant date. Following the stock grant, he directly holds 24,517 common shares, plus the newly granted options.

Insider Trade Summary

Grant/Award: 3,980 shares

Grant/Award 2 txns

Insider HARRIS C MARTIN

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	2,424	$0.00	$0.00
Grant/Award	Common Stock	1,556	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 2,424 contracts (Direct); Common Stock — 24,517 shares (Direct)

Footnotes (3)

1. F1. Annual director stock grant under the issuer's incentive compensation plan.
2. F2. Annual director stock option grant under the issuer's incentive compensation plan.
3. F3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.

Key Figures

Director stock grant: 1,556 shares Stock options granted: 2,424 options Option exercise price: $86.74 per share +2 more

5 metrics

Director stock grant 1,556 shares Annual director stock grant on May 11, 2026

Stock options granted 2,424 options Stock Option (Right to Buy) granted May 11, 2026

Option exercise price $86.74 per share Exercise price for 2,424 stock options

Shares held after grant 24,517 shares Total direct Common Stock holdings after equity grant

Option expiration date May 11, 2034 Expiration of stock options for 2,424 shares

Key Terms

incentive compensation plan, Annual director stock grant, stock option, exercisable in equal annual installments

4 terms

incentive compensation plan financial

"Annual director stock grant under the issuer's incentive compensation plan."

An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.

Annual director stock grant financial

"Annual director stock grant under the issuer's incentive compensation plan."

stock option financial

"Annual director stock option grant under the issuer's incentive compensation plan."

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercisable in equal annual installments financial

"Option becomes exercisable in equal annual installments over three years beginning on the first anniversary"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Colgate-Palmolive (CL) director Harris C. Martin report in this Form 4?

He reported receiving equity awards as director compensation, including 1,556 shares of Common Stock and stock options for 2,424 shares. These were granted under Colgate-Palmolive’s incentive compensation plan on May 11, 2026.

How many Colgate-Palmolive (CL) shares does Harris C. Martin hold after the grant?

After the grant, Harris C. Martin directly holds 24,517 shares of Colgate-Palmolive Common Stock. This figure reflects his position following the award of 1,556 additional shares as part of the company’s annual director stock grant program.

What are the terms of the new stock options granted to the Colgate-Palmolive (CL) director?

He received options covering 2,424 shares of Common Stock at an exercise price of $86.74 per share. These options expire on May 11, 2034 and vest in equal annual installments over three years starting one year after the grant date.

Are the Colgate-Palmolive (CL) Form 4 transactions open-market buys or sales?

The transactions are compensation-related grants, not open-market trades. Both the 1,556-share stock award and the 2,424-share stock option grant are labeled as grants or awards under Colgate-Palmolive’s incentive compensation plan, with no purchase price paid.

How do the new equity awards for the Colgate-Palmolive (CL) director vest over time?

The 1,556-share stock grant is an annual director stock grant, while the 2,424-share stock options vest in three equal annual installments. Vesting begins on the first anniversary of the May 11, 2026 grant date, spreading the option exercisability over three years.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 04:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HARRIS C MARTIN

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/11/2026		A(1)		1,556	A	$0.0000	24,517	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$86.74	05/11/2026		A(2)		2,424		(3)	05/11/2034	Common Stock	2,424	$0.0000	2,424	D

Explanation of Responses:

1. Annual director stock grant under the issuer's incentive compensation plan.

2. Annual director stock option grant under the issuer's incentive compensation plan.

3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.

	/s/ Kristine Hutchinson, Attorney-in-Fact	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)